Christopher Cutler Co-Authors Second Edition of Accountants’ Liability Book
March 24, 2017
Given the highly complex and regulated environment of the accounting profession, it is more important than ever for accountants and auditors to understand the scrutiny of the Securities and Exchange Commission, the Public Company Accounting Oversight Board and state boards of accountancy. It is equally important for accountants and auditors to appreciate the wide range of claims that can be asserted in civil litigation, including federal securities claims and professional liability claims.
In the Second Edition of Accountants’ Liability published by Practising Law Institute (PLI), Foley & Lardner LLP partner and vice-chair of the firm’s Securities Enforcement & Litigation practice, Christopher Cutler, provides new insight to defend claims against, and better represent, accounting firms and their accountants and auditors. The book is available for purchase online.
In the Second Edition of Accountants’ Liability published by Practising Law Institute (PLI), Foley & Lardner LLP partner and vice-chair of the firm’s Securities Enforcement & Litigation practice, Christopher Cutler, provides new insight to defend claims against, and better represent, accounting firms and their accountants and auditors. The book is available for purchase online.
Author(s)
Related Insights
April 28, 2026
Health Care Law Today
Medicare Payment Suspensions Emerge as a Key Tool in Federal Anti-Fraud Efforts — Focus on California Hospices
Medicare payment suspensions result in a cessation of payments for Medicare services until the suspension is resolved, typically several months after the initial action to suspend. Payments withheld will then be released after recoupment of any determined overpayments. The Trump Administration has stated that it will aggressively use its authority (created by the 2010 Affordable Care Act) to suspend payments based upon a credible allegation of fraud. Below we set forth the context for such suspensions, as well as the key parameters for such actions.
April 28, 2026
Health Care Law Today
Psychedelics and the Executive Order: From Schedule I to Treatment Priority
On April 18, 2026, President Donald Trump signed an executive order titled Accelerating Medical Treatments for Serious Mental Illness, directing federal agencies to expedite the research, review, and approval of psychedelic drugs as potential treatments for serious mental health conditions. The Order represents a significant federal policy shift aimed at addressing what the Trump Administration describes as a crisis of serious mental illness in America, with particular emphasis on patients whose conditions have not responded to standard therapies.
April 27, 2026
Labor & Employment Law Perspectives
The Elusive PAGA Early Evaluation Conference
According to the PAGA reform statute, employers with at least 100 employees can seek an Early Evaluation Conference within the time required to respond to the lawsuit to allow a neutral evaluator to decide a wide range of issues,